Trial intelligence / Profile preview

Bone marrow progenitor cell dysfunction in chronic kidney disease

NL-OMON41569Active, not recruiting

Sponsor
University Medical Center Utrecht
Start
Jul 2013
Countries
1
01

Overview

Open-label trial in chronic kidney disease (CKD) (2 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Quantification and characterization of bone marrow stem and progenitor cells, Functional assessment of bone marrow stem and progenitor cells and 2 more. Started Jul 2013; status: active, not recruiting.

02

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NL-OMON41569.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON41569.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call